Co-Founder
JR Rahn is a technology and biotechnology entrepreneur focused on building category-defining companies at the intersection of neuroscience and innovation. He is the Founder and former Chief Executive Officer of Definium Therapeutics (NASDAQ: DFTX), formerly Mind Medicine Inc., a clinical-stage biopharmaceutical company developing novel therapies for addiction, anxiety, and other central nervous system disorders. After his leadership, the company went on to raise more than $500 million in public and private capital and built a multidisciplinary team spanning drug development, regulatory strategy, and capital markets.
Prior to founding the company, JR worked with high-growth technology companies in Silicon Valley, including Uber Technologies Inc., and was selected to participate in Y Combinator, one of the world’s leading startup accelerators.
He earned a Bachelor of Arts in Chinese Language and Government from Hamilton College.
Leadership & Board of Directors
Founders & Advisors
Co-Founder, Chief Executive Officer & Director
Chief Scientific Officer
Chief Medical Officer
Chief Operations Officer
Chief Financial Officer
Interim Head of Regulatory Affairs
Vice President of Technical Operations
Director of Administration
Director of Corporate Development & Operations
Senior Director of Quality Assurance
Anesthesia & Medical Advisor
Scientific Co-Founder & Advisor
Anesthesia & Medical Advisor
Scientific Co-Founder & Medical Advisor
Scientific Advisor
Strategic Advisor, APAC Region
Scientific Advisor
Scientific Advisor
Co-Founder
